NewAmsterdam Pharma Co. NV (NAMS)
33.55
-0.59
(-1.73%)
USD |
NASDAQ |
May 19, 15:17
NewAmsterdam Pharma Total Liabilities (Quarterly) : 67.42M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 629.36M |
| ProQR Therapeutics NV | 70.79M |
| argenx SE | -- |
| Pharming Group NV | 220.41M |
| Arcutis Biotherapeutics, Inc. | 270.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.64M |
| Shareholders Equity (Quarterly) | 665.22M |
| Current Ratio | 9.760 |
| Net Debt Paydown Yield | 0.00% |